Analysis-Drug giants eye China for deals despite growing Sino-US tensions
By Andrew Silver and Kane Wu SHANGHAI/HONG KONG (Reuters) - Some of the biggest global drugmakers, undeterred by mounting Sino-U.S. tensions, are scouring for deals in China to replenish drug pipelines and boost their presence in the world's second …